| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.026 | 0.7 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.7 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.8 |